BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

Completed

Conditions: Amyotrophic Lateral Sclerosis

First Posted Date: 2008-02-21

Last Posted Date: 2014-09-25

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 89

Registration Number: NCT00620698

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States
🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States

and more 5 locations

Premenstrual Dysphoric Disorder and Antiepileptic Drugs

Completed

Conditions: Epilepsy

Interventions: Drug: Lamotrigine
Other: No Intervention
Drug: Levetiracetam
Drug: Carbamazepine

First Posted Date: 2008-02-11

Last Posted Date: 2018-10-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 80

Registration Number: NCT00612235

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Newton-Wellesley Hospital, Newton, Massachusetts, United States

RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma

Not Applicable

Withdrawn

Conditions: Renal Cell Carcinoma

First Posted Date: 2008-01-25

Last Posted Date: 2013-02-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT00601120

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage

Phase 1

Completed

Conditions: Intracerebral Hemorrhage

Interventions: Drug: Deferoxamine Mesylate

First Posted Date: 2008-01-22

Last Posted Date: 2018-01-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00598572

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period

Phase 2

Completed

Conditions: Delirium

Interventions: Drug: donepezil
Drug: Placebo

First Posted Date: 2008-01-04

Last Posted Date: 2014-08-22

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 16

Registration Number: NCT00586196

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Efficacy and Safety of 500mg of Fulvestrant

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: Fulvestrant

First Posted Date: 2008-01-03

Last Posted Date: 2024-03-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 40

Registration Number: NCT00585507

Locations: 🇺🇸
Massachusetts General Hosptial, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 2 locations

Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Capecitabine
Drug: Oxaliplatin

First Posted Date: 2008-01-03

Last Posted Date: 2017-04-10

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 40

Registration Number: NCT00585078

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma

Phase 2

Completed

Conditions: Metastatic Renal Cell Carcinoma

Interventions: Drug: HD IL2

First Posted Date: 2007-11-07

Last Posted Date: 2024-08-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 123

Registration Number: NCT00554515

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Tracheobronchomalacia: Treatment Outcomes

Completed

Conditions: Tracheomalacia
Tracheobronchomalacia

First Posted Date: 2007-10-30

Last Posted Date: 2017-02-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 150

Registration Number: NCT00550602

Locations: 🇺🇸
Beth Israel Deaconess Medical Center- Division of Interventional Pulmonology, Boston, Massachusetts, United States

Outcomes of a Deep Inferior Epigastric Perforator Flap Program

Completed

Conditions: Breast Cancer

First Posted Date: 2007-10-15

Last Posted Date: 2022-12-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 977

Registration Number: NCT00543907

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy